Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Recs

0
Player Avatar eksummers620 (57.47) Submitted: 12/29/2011 9:29:52 PM : Outperform Start Price: $46.10 VRX Score: +0.34

This is principal holding of the Sequoia Fund.

Featured Broker Partners


Advertisement